logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

MICROPORT NEURO (02172) spent approximately HKD 1.9513 million to repurchase 250,000 shares on September 19th.

date
20:35 19/09/2024
avatar
GMT Eight
Minimally Invasive Neurosciences (02172) announced on September 19, 2024, to repurchase approximately 1.9513 million Hong Kong dollars...
MICROPORT NEURO (02172) has announced on September 19, 2024, that they will repurchase 250,000 shares at a cost of approximately 1.9513 million Hong Kong dollars. The repurchase price per share is between 7.77 and 7.86 Hong Kong dollars.
Related Articles
HK Stock
PCPD (00432) plans to issue $500 million guaranteed notes due in 2029 with a coupon rate of 7.5%.
HK Stock
SBP GROUP (01177) reached an exclusive strategic cooperation agreement with GlaxoSmithKline.
HK Stock
HK SH ALLIANCE (01001) subsidiary is submitting a bid for the construction of a BOT project for a large building in Tsing Yi, Hong Kong. The contract period is for 30 years.
PCPD (00432) plans to issue $500 million guaranteed notes due in 2029 with a coupon rate of 7.5%.
HK Stock
SBP GROUP (01177) reached an exclusive strategic cooperation agreement with GlaxoSmithKline.
HK Stock
HK SH ALLIANCE (01001) subsidiary is submitting a bid for the construction of a BOT project for a large building in Tsing Yi, Hong Kong. The contract period is for 30 years.
HK Stock
RECOMMEND
Global Cellular IoT Growth Slows Sharply as China Market Weakens
Global Cellular IoT Growth Slows Sharply as China Market Weakens
icon
11/05/2026
Middle East Conflict Opens Historic Window for China’s Metal Exports
Middle East Conflict Opens Historic Window for China’s Metal Exports
icon
11/05/2026
DeepSeek’s Potential USD 45 Billion Valuation Highlights China’s Large‑Model Financing Surge
DeepSeek’s Potential USD 45 Billion Valuation Highlights China’s Large‑Model Financing Surge
icon
11/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.